These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7001974)

  • 1. Influence of small increments of epinephrine on glucose tolerance in normal humans.
    Hamburg S; Hendler R; Sherwin RS
    Ann Intern Med; 1980 Oct; 93(4):566-8. PubMed ID: 7001974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.
    Tse TF; Clutter WE; Shah SD; Miller JP; Cryer PE
    J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
    Eigler N; Saccà L; Sherwin RS
    J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.
    Newman WP; Brodows RG
    J Clin Endocrinol Metab; 1982 Sep; 55(3):496-501. PubMed ID: 7047549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine-induced hypoaminoacidemia in normal and diabetic human subjects: effect of beta blockade.
    Shamoon H; Jacob R; Sherwin RS
    Diabetes; 1980 Nov; 29(11):875-81. PubMed ID: 7000585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach.
    Vicini P; Avogaro A; Spilker ME; Gallo A; Cobelli C
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E78-84. PubMed ID: 12067846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
    Clutter WE; Bier DM; Shah SD; Cryer PE
    J Clin Invest; 1980 Jul; 66(1):94-101. PubMed ID: 6995479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose intolerance in thyrotoxic rats: role of insulin, glucagon, and epinephrine.
    Ikeda T; Mokuda O; Tominaga M; Mashiba H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E843-9. PubMed ID: 3059820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans.
    Shamoon H; Hendler R; Sherwin RS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1235-41. PubMed ID: 7014600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia.
    Sotsky MJ; Shilo S; Shamoon H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):9-16. PubMed ID: 2642489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans.
    Laurent D; Petersen KF; Russell RR; Cline GW; Shulman GI
    Am J Physiol; 1998 Jan; 274(1):E130-8. PubMed ID: 9458758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epinephrine on amino acid and energy metabolism in humans.
    Matthews DE; Pesola G; Campbell RG
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E948-56. PubMed ID: 2193535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin antagonistic effects of epinephrine and glucagon in the dog.
    Saccà L; Eigler N; Cryer PE; Sherwin RS
    Am J Physiol; 1979 Dec; 237(6):E487-92. PubMed ID: 517645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Shau V; Benson EM; Lewis M; Snowden RT; Greene JE; Neal DW; Cherrington AD
    Am J Physiol; 1997 Oct; 273(4):E674-81. PubMed ID: 9357794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs.
    el-Tayeb KM; Brubaker PL; Vranic M; Lickley HL
    Diabetes; 1985 Dec; 34(12):1293-300. PubMed ID: 2998913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.